David Hochman

David Hochman

Amministratore Delegato presso ORCHESTRA BIOMED HOLDINGS, INC.

Patrimonio netto: 6 M $ in data 31/05/2026

50 anni
Health Technology
Finance
Health Services

Profilo

David P.
Hochman
is the founder of OPKO Biologics Ltd. (2001), Prescient Medical, Inc. (2004), Caliber Therapeutics LLC (2009), FreeHold Surgical LLC (2011), BackBeat Medical LLC (2011), Corbus Pharmaceuticals Holdings, Inc. (2013), Orchestra BioMed, Inc. (2018), and Orchestra Biomed Holdings, Inc. (2020).
Titles held at these companies included Director at OPKO Biologics Ltd. (2005–2007), Director at Caliber Therapeutics LLC (2009–2018), Director at FreeHold Surgical LLC (2011–2018), Director at BackBeat Medical LLC (2018), Director at Corbus Pharmaceuticals Holdings, Inc. (2013–2020), Chairman & Chief Executive Officer at Orchestra BioMed, Inc. (2018–present), and Chairman & Chief Executive Officer at Orchestra Biomed Holdings, Inc. (2020–present).
Current jobs include Chairman at Motus G.I.
Medical Technologies Ltd. (2011–present), Director at Corbus Pharmaceuticals, Inc., Director at Aids Action Foundation, and President & Director at Mollie Parnis Livingston Foundation, Inc.Former jobs include Chief Executive Officer at Spencer Trask Edison Partners LLC (1997–2006), Vice Chairman at Naked Brand Group, Inc. (2014–2017), Chairman at Vital Access Corp.
(2008–2017), Director at Orchestra Therapeutics, Inc., Managing Director at Augment Securities, Inc. (2005), Director at Journey Health, Inc. (Virginia) (2013–2018), Director at Citizens Committee for New York City (1999–2019), Director at Adgero Biopharmaceuticals Holdings, Inc. (2015–2020), Independent Director at Motus GI Holdings, Inc. (2023), Advisor at Idera Pharmaceuticals, Inc., Advisor at Health Dialog Services Corp., Managing Partner at Orchestra Medical Ventures LLC, and President at Accelerated Technologies, Inc. (Texas) (2009–2019).
Education includes undergraduate degree from the University of Michigan, conferred in 1997.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
10/06/2026 1.506.085 ( 2,79% ) 6 M $ 31/05/2026

Posizioni attive di David Hochman

SocietàPosizioneInizio
ORCHESTRA BIOMED HOLDINGS, INC. Amministratore Delegato 25/05/2020
Direttore/Membro del Consiglio -
Amministratore Delegato 01/05/2018
Presidente 01/09/2011
Mollie Parnis Livingston Foundation, Inc.
Presidente -
Direttore/Membro del Consiglio -

Precedenti posizioni note di David Hochman

SocietàPosizioneFine
MOTUS GI HOLDINGS, INC. Presidente 13/04/2023
CORBUS PHARMACEUTICALS HOLDINGS, INC. Fondatore 11/09/2020
Direttore/Membro del Consiglio 01/01/2020
░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di David Hochman

Formazione di David Hochman

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

81

Relazioni di 1° grado

26

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private26

Finance

Health Technology

Health Services

Finance

Distribution Services

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Services

Consumer Services

Finance

Health Technology

Producer Manufacturing

Spencer Trask Edison Partners LLC

Health Technology

Electronic Technology

Commercial Services

Mollie Parnis Livingston Foundation, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. David Hochman
-40% : Prolongation exceptionnelle ➤➤➤➤
g
:
:
ENTRA ORA